Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Diagnostics › Molecular Diagnostics › GeneCapture To Enter Point of Care MDx Market With Affordable Infectious Disease Screening Platform

GeneCapture To Enter Point of Care MDx Market With Affordable Infectious Disease Screening Platform

Apr 27, 2018
|
John Gilmore
Premium

NEW YORK (GenomeWeb) – Startup GeneCapture has announced that it plans to enter the point of care diagnostics market by screening for common infectious diseases in vulnerable areas with its portable genotyping platform.

Based in Huntsville, Alabama, GeneCapture spun out of the University of Alabama at Huntsville (UAH) in 2009 as a partnership between CEO Peggy Sammon and CTO Krishnan Chittur. Chittur previously developed the original gene probe technology underlying GeneCapture's platform at UAH and later applied for a patent.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Mar
18
Featured Webinar

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Featured Webinar

Think Globally, Act Locally: The Importance of Coordinated Global and Community Genetic Surveillance Programs

Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Featured Webinar

Development and Commercialization of a Novel CRISPR-Based SARS CoV-2 Test

Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test. 

What's Popular?

In Molecular Diagnostics

  1. AMP Survey Finds Significant Decline in Molecular Cancer Testing Due to COVID-19 Pandemic

  2. SARS-CoV-2 Test Pooling Studies Offer Insights for Implementing, Optimizing Approaches

  3. NeoGenomics Q4 Revenue Grows 18 Percent, CEO to Retire

  4. Walgreens to Sell Labcorp COVID-19 PCR Home Collection Kits Over-the-Counter

  5. WuXi Diagnostics Closes $150M Series B Financing Round

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.